Table 1 Subject Demography.
From: The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Variable | Value |
|---|---|
Age/years | 31 (20 - 46) |
Gender (Male/Female) | 13/11 |
FEV1 % predicted | 90.1 (71.3 - 111.8) |
Allergen used for bronchial challenge | 14 dust mite, 5 cat dander, 5 grass mix |